Gail Schoettler appointed non-executive Chair of the Board
Company: Riot
The claim, verbatim
Gail Schoettler became non-executive Chair of the Board effective October 7, 2010
Source (primary)
Riot PRE 14A filed 2010-10-12 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “Effective as of October 7, 2010, Gail Schoettler became Chair of the Board of the Directors of the Company”
How we checked this
Checked on September 29, 2026. The cited source supports every part of this claim.
The proxy statement says that effective October 7, 2010, Gail Schoettler became Chair of the Board, and it describes the role as non-executive Chair.
Confirmed in the source:
- Gail Schoettler became Chair of the Board of AspenBio Pharma effective October 7, 2010
- Her role is non-executive Chair of the Board
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997310001084/appy_pre14a.htm) in full (159,768 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot PRE 14A filed 2010-10-12
Quote: “Effective as of October 7, 2010, Gail Schoettler became Chair of the Board of the Directors of the Company”